Dov Elefant, Chief Financial Officer at Cellectar Biosciences, Inc. (CLRB), bought 4,348 shares at $1.15 ($5K) on 2020-06-05, disclosed to the SEC on 2020-06-08.
Open-market purchase of $5k CLRB by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |